BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 21, 2010
View Archived Issues
Promising clinical effects with topical miltefosine and clobetasol in cutaneous mastocytosis
Read More
Novel delivery system for targeted radiotherapy of breast cancer shows promise in vitro
Read More
Smo receptor antagonists described by Amgen for cancer therapy
Read More
Xoma summarizes clinical development of its lead product XOMA-052
Read More
GenVec reports key event in phase III trial of TNFerade in advanced pancreatic cancer
Read More
Enrollment completed in phase II portion of phase II/III trial of Taksta
Read More
Circassia begins phase II trials of ToleroMune in house dust mite and cat allergies
Read More
EMEA Pediatric Committee grants product-specific waivers for StemEx
Read More
Durect initiates pivotal phase III Posidur trial
Read More
Acceleron adds two novel programs to development pipeline
Read More
Verona Pharma provides pipeline update
Read More
Pfizer obtains approval for Xalacom for glaucoma and ocular hypertension
Read More
Sunitinib activity limited in patients with squamous cell carcinoma of the head and neck
Read More
Novartis receives Japanese approval for Equa, Exforge and Afinitor
Read More
Daiichi granted Japanese approval to manufacture and market Rezaltas for hypertension
Read More
Cleveland BioLabs initiates dosing in phase Ib trial of CBLB-502
Read More
Siga discloses antiviral compounds for the treatment of dengue fever
Read More
Novel S1P1 receptor agonists in early development at Arena
Read More
NeuroSearch presents nAChR ligands for the treatment of cognitive disorders
Read More
Nycomed pays milestone payment to Immunomedics for veltuzumab
Read More
Novo Nordisk obtains approval in Japan for Victoza for type 2 diabetes
Read More
Matrix Laboratories describes PDE IV inhibitors for asthma therapy
Read More
PTC starts additional ataluren study in Duchenne/Becker muscular dystrophy
Read More
Spear Therapeutics discloses novel compounds for cancer treatment
Read More
Phase II data show ixabepilone to be safe and efficacious in ovarian cancer
Read More